Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1990 1
1992 1
1996 2
1999 2
2000 1
2002 1
2006 1
2007 3
2009 2
2010 4
2012 1
2013 4
2014 6
2015 2
2016 1
2017 3
2018 2
2019 2
2020 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Esophageal Poorly Differentiated Squamous Cell Carcinoma"
Page 1
Molecular pathology and potential therapeutic targets in esophageal basaloid squamous cell carcinoma.
Saito T, Mitomi H, Yao T. Saito T, et al. Int J Clin Exp Pathol. 2015 Mar 1;8(3):2267-73. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26045734 Free PMC article. Review.
Basaloid squamous cell carcinoma (BSCC) is a rare and poorly differentiated variant of typical squamous cell carcinoma. Emerging studies show that genetic alterations are more frequent in BSCC than in conventional SCC, and s …
Basaloid squamous cell carcinoma (BSCC) is a rare and poorly differentiated variant of typical squamou …
Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model.
Cheng X, Zhang Y, Zhu M, Sun R, Liu L, Li X. Cheng X, et al. BMC Med Imaging. 2023 Oct 2;23(1):145. doi: 10.1186/s12880-023-01089-0. BMC Med Imaging. 2023. PMID: 37779188 Free PMC article.
BACKGROUND: Radical concurrent chemoradiotherapy (CCRT) is frequently used as the first-line treatment for patients with locally advanced esophageal cancer. Unfortunately, some patients respond poorly. To predict response to radical concurrent chemoradiotherapy in p …
BACKGROUND: Radical concurrent chemoradiotherapy (CCRT) is frequently used as the first-line treatment for patients with locally advanced …
Esophageal Cancer: Associations With (pN+) Lymph Node Metastases.
Rice TW, Ishwaran H, Hofstetter WL, Schipper PH, Kesler KA, Law S, Lerut EM, Denlinger CE, Salo JA, Scott WJ, Watson TJ, Allen MS, Chen LQ, Rusch VW, Cerfolio RJ, Luketich JD, Duranceau A, Darling GE, Pera M, Apperson-Hansen C, Blackstone EH. Rice TW, et al. Ann Surg. 2017 Jan;265(1):122-129. doi: 10.1097/SLA.0000000000001594. Ann Surg. 2017. PMID: 28009736 Free PMC article.
RESULTS: pN+, number of positive nodes, and pN subclassification were associated with increasing depth of cancer invasion (pT), increasing cancer length, decreasing cancer differentiation (G), and more regional lymph nodes resected. Lymphadenectomy necessary to accurately …
RESULTS: pN+, number of positive nodes, and pN subclassification were associated with increasing depth of cancer invasion (pT), increasing c …
Protease-activated receptor (PAR)1, PAR2 and PAR4 expressions in esophageal squamous cell carcinoma.
Li SM, Jiang P, Xiang Y, Wang WW, Zhu YC, Feng WY, Li SD, Yu GY. Li SM, et al. Dongwuxue Yanjiu. 2014 Sep;35(5):420-5. doi: 10.13918/j.issn.2095-8137.2014.5.420. Dongwuxue Yanjiu. 2014. PMID: 25297082 Free PMC article.
Our results indicate that the expression of PAR1 and PAR2 in esophageal squamous cell carcinoma is increased but PAR4 is decreased. Hypermethylation of the promoter of the PAR4 gene may contribute to reduced expression of PAR4 in esophageal s …
Our results indicate that the expression of PAR1 and PAR2 in esophageal squamous cell carcinoma is increased but …
NRF2/ACSS2 axis mediates the metabolic effect of alcohol drinking on esophageal squamous cell carcinoma.
Odera JO, Xiong Z, Huang C, Gu N, Yang W, Githang'a J, Odera E, Paiboonrungruang C, Chen X. Odera JO, et al. Biochem J. 2020 Aug 28;477(16):3075-3089. doi: 10.1042/BCJ20200452. Biochem J. 2020. PMID: 32776152 Free PMC article.
Alcohol drinking is a leading risk factor for the development of esophageal squamous cell carcinoma (ESCC). However, the molecular mechanisms of alcohol-associated ESCC remain poorly understood. ...When NRF2 is hyperactive in cancer cells, howev …
Alcohol drinking is a leading risk factor for the development of esophageal squamous cell carcinoma (ESCC). Howe …
Risk of tumor implantation in percutaneous endoscopic gastrostomy in the upper aerodigestive tumors.
Vincenzi F, De Caro G, Gaiani F, Fornaroli F, Minelli R, Leandro G, Di Mario F, De' Angelis GL. Vincenzi F, et al. Acta Biomed. 2018 Dec 17;89(8-S):117-121. doi: 10.23750/abm.v89i8-S.7894. Acta Biomed. 2018. PMID: 30561429 Free PMC article. Review.
Percutaneous endoscopic gastrostomy (PEG) has become a mainstay in providing enteral access for patients with obstructive head, neck and esophageal tumors. Tumor cell implantation is a rare complication in patients with aerodigestive cancers, who have undergone PEG …
Percutaneous endoscopic gastrostomy (PEG) has become a mainstay in providing enteral access for patients with obstructive head, neck and …
Loss of TACSTD2 contributed to squamous cell carcinoma progression through attenuating TAp63-dependent apoptosis.
Wang F, Liu X, Yang P, Guo L, Liu C, Li H, Long S, Shen Y, Wan H. Wang F, et al. Cell Death Dis. 2014 Mar 20;5(3):e1133. doi: 10.1038/cddis.2014.96. Cell Death Dis. 2014. PMID: 24651436 Free PMC article.
Although TACSTD2, was reported to be overexpressed in many epithelial tumors, which has increased interest in using it as a molecular target for cancer therapy, the role of TACSTD2 in carcinogenesis of squamous cell carcinoma (SCC) is largely unclear and cont …
Although TACSTD2, was reported to be overexpressed in many epithelial tumors, which has increased interest in using it as a molecular target …
Optimum lymphadenectomy for esophageal cancer.
Rizk NP, Ishwaran H, Rice TW, Chen LQ, Schipper PH, Kesler KA, Law S, Lerut TE, Reed CE, Salo JA, Scott WJ, Hofstetter WL, Watson TJ, Allen MS, Rusch VW, Blackstone EH. Rizk NP, et al. Ann Surg. 2010 Jan;251(1):46-50. doi: 10.1097/SLA.0b013e3181b2f6ee. Ann Surg. 2010. PMID: 20032718
Optimum number of nodes that should be resected to maximize 5-year survival was determined by random forest multivariable regression. RESULTS: For pN0M0 moderately and poorly differentiated cancers, and all node-positive (pN+) cancers, 5-year survival improve …
Optimum number of nodes that should be resected to maximize 5-year survival was determined by random forest multivariable regression. …
A patient with tracheoesophageal fistula and esophageal cancer after radiotherapy.
Hagendoorn J, Schipper ME, Cloïn A, Ramjankhan FZ, Siersema PD, van Hillegersberg R. Hagendoorn J, et al. Nat Rev Gastroenterol Hepatol. 2010 Dec;7(12):702-6. doi: 10.1038/nrgastro.2010.171. Epub 2010 Nov 9. Nat Rev Gastroenterol Hepatol. 2010. PMID: 21063396 Review.
BACKGROUND: A 63-year-old woman presented with dysphagia owing to proximal esophageal stenosis 27 years after she received radiation therapy for Hodgkin disease. ...INVESTIGATIONS: Medical history and physical examination, pathology and immunohistochemistry, bronchoscopy, …
BACKGROUND: A 63-year-old woman presented with dysphagia owing to proximal esophageal stenosis 27 years after she received radiation …
Treatment of clinical T2N0M0 esophageal cancer.
Hardacker TJ, Ceppa D, Okereke I, Rieger KM, Jalal SI, LeBlanc JK, DeWitt JM, Kesler KA, Birdas TJ. Hardacker TJ, et al. Ann Surg Oncol. 2014 Nov;21(12):3739-43. doi: 10.1245/s10434-014-3929-6. Epub 2014 Jul 22. Ann Surg Oncol. 2014. PMID: 25047477
BACKGROUND: Management of clinical T2N0M0 (cT2N0M0) esophageal cancer remains controversial. ...On multivariate analysis, adenocarcinoma (p = 0.001) and pN0 after resection (p = 0.01) were significant predictors of survival. CONCLUSIONS: EUS was inaccurate in stagin …
BACKGROUND: Management of clinical T2N0M0 (cT2N0M0) esophageal cancer remains controversial. ...On multivariate analysis, aden …
41 results